To view this email as a web page, click here.

 
Focus on DME/DR
 
Sustained DRSS improvement with aflibercept
Treating DR with anti-VEGF agents is an alternative to panretinal laser. In some studies it has been found that “significantly more eyes with DME” can have a ≥2-step improvement in diabetic retinopathy severity scores than in eyes treated with laser, according to Rishi Singh, MD.
Find out
ADVERTISEMENT
 
Several cyst characteristics linked to ischemia in DME
image description here The likelihood of macular ischemia increases with larger cyst diameters, central subfield thickness, and the extent of outer retinal damage, according to a retrospective review of 250 eyes (186 patients) with diabetic macular edema (DME).

Learn more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.